Posts

Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance

Applications of macrocyclic molecules in cancer therapy...

Nov 29, 2023

This review was designed by Professor Xiaoling Song and Professor Biao Jiang and...

What is Cellular Agriculture? The world population is expected to reach 9.7 billion by 2050. With it will come a doubling in the amount of animal protein we consume.

What is Cellular Agriculture? The world population is e...

Nov 29, 2023

In his Value Creation project in Cell Ag class, Tufts senior Adham Ali faced an ...

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

GSK Drops Bowel Disease Asset Amid Immunology Unit Changes

Nov 28, 2023

GlaxoSmithKline (GSK) has jolted the pharmaceutical community with its abrupt de...

AstraZeneca’s Strategic Leap into KRAS G12D with Chinese Biotech Collaboration

AstraZeneca’s Strategic Leap into KRAS G12D with Chines...

Nov 28, 2023

AstraZeneca has secured a significant deal in the competitive field of cancer re...

Novovax’s Omicron-targeting Covid-19 vaccine obtains WHO emergency listing

Novovax’s Omicron-targeting Covid-19 vaccine obtains WH...

Nov 28, 2023

Novovax has been granted emergency use listing (EUL) by the World Health Organi...

Boehringer to leverage IBM’s technologies for antibody discovery

Boehringer to leverage IBM’s technologies for antibody ...

Nov 28, 2023

Boehringer Ingelheim has entered an agreement with IBM to leverage the latter’s...

Abeona’s cell therapy secures priority approval date for rare skin disorder

Abeona’s cell therapy secures priority approval date fo...

Nov 28, 2023

Abeona Therapeutics’s pz-cel (prademagene zamikeracel) has received a US Fo...

FDA accepts Orexo’s NDA for opioid overdose medication

FDA accepts Orexo’s NDA for opioid overdose medication

Nov 28, 2023

The US Food and Drug Administration (FDA) has accepted Orexo’s new drug applica...

Radiopharmaceuticals reach record high with $408m in venture financing for 2023

Radiopharmaceuticals reach record high with $408m in ve...

Nov 28, 2023

Venture financing for innovative radiopharmaceutical drugs witnessed an approxi...

FDA rejects Aldeyra’s dry eye drug, asks for more clinical data

FDA rejects Aldeyra’s dry eye drug, asks for more clini...

Nov 28, 2023

The US Food and Drug Administration (FDA) has issued a complete response letter...

Acelyrin claims errors by CRO Fortrea led to late-stage trial downfall

Acelyrin claims errors by CRO Fortrea led to late-stage...

Nov 28, 2023

Immunology biotech Acelyrin has determined that its CRO partner Fortrea is resp...

Bayer’s stock drops to new 18-year low after asundexian trial termination

Bayer’s stock drops to new 18-year low after asundexian...

Nov 28, 2023

Bayer’s stock price has plummeted to its lowest since 2005 after a clinical tri...

CTO Europe 2023: Cancer clinical trials shift as sector goes digital

CTO Europe 2023: Cancer clinical trials shift as sector...

Nov 28, 2023

Building on the increased adoption of digital trial capabilities due to the Cov...

Emergent wins $75m BARDA contact for anthrax vaccine

Emergent wins $75m BARDA contact for anthrax vaccine

Nov 28, 2023

Emergent BioSolutions has secured a $75m contract for the acquisition of the FD...

Opinion: The next Census could undercount the number of disabled Americans by 20 million

Opinion: The next Census could undercount the number of...

Nov 27, 2023

About 20 million disabled people may be erased if the U.S. Census Bureau moves f...

New research supports potential link between low-level lead exposure and liver injury

New research supports potential link between low-level ...

Nov 27, 2023

New research supports potential link between low-level lead exposure and liver i...